Healthcare Professional Survey to Assess the Effectiveness of Additional Risk Minimization Measures for Prescribing and Administration of Concentrated Insulin Human (Humulin R U-500 KwikPen) (B5K-MC-B012)

06/11/2017
08/11/2017
EU PAS number:
EUPAS21539
Study
Planned
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B5K-MC-B012_EU_PAS_Registered

English (1.06 MB - PDF) View document
Study results
Study report
Other information